In today’s episode, Marc talks about the Fed’s quarter-point interest rate hike and what it means for the markets. To help sort through all the potential repercussions, Marc invites The Oxford Club’s Emerging Trends Strategist, Matthew Carr, to join him. Matt offers his perspective - based on years of data - and shares his thoughts on where stocks are headed in 2016.
Later, Marc talks about the recent legal troubles of former Turing Pharmaceuticals CEO Martin Shkreli. Shkreli famously jacked up the price of the drug Daraprim by more than 5,000% and was arrested last week for securities fraud.